Latest stories on OKYO
OKYO Pharma CSO Increases Stake Ahead of Planned Phase 3 Trial
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer | OKYO Stock News
StockTitan56 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
Business Insider56 · neutralgeneral
OKYO Pharma to Present Late-Stage Ophthalmic Pipeline at BTIG Biotechnology Conference 2026
TipRanks56 · neutralproduct/pr
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Business Insider56 · neutralgeneral
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026 | OKYO Stock News
StockTitan56 · neutralgeneral
OKYO Pharma Director Ups Stake Ahead of Planned Phase 3 Neuropathic Corneal Pain Trial
TipRanks56 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Director
Business Insider55 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Director | OKYO Stock News
StockTitan56 · neutralgeneral
OKYO Pharma CEO Boosts Stake With Nasdaq Share Purchase
TipRanks63 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer | OKYO Stock News
StockTitan53 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chairman
Business Insider63 · neutralgeneral
OKYO Pharma Executive Boosts Shareholding Ahead of Planned Phase 3 NCP Trial
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director | OKYO Stock News
StockTitan56 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer | OKYO Stock News
StockTitan56 · neutralgeneral
OKYO Pharma to Present Ophthalmology Pipeline Ahead of Phase 3 Urcosimod Trial
TipRanks56 · neutralproduct/pr
OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference | OKYO Stock News
StockTitan56 · neutralproduct/pr
OKYO Pharma chairman increases stake with share purchase
Seeking Alpha58 · neutralgeneral
OKYO Pharma Chairman Boosts Stake Ahead of Phase 3 Neuropathic Corneal Pain Trial
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chairman | OKYO Stock News
StockTitan63 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chairman
Business Insider63 · neutralgeneral
OKYO Pharma files annual report, highlights cash position and Phase 3 trial plans
Yahoo Top54 · neutralgeneral
OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans
Business Insider59 · neutralgeneral
OKYO Pharma Secures FDA Backing to Advance Urcosimod into Global Phase 3 Trial for Neuropathic Corneal Pain
TipRanks67 · bullishproduct/pr